TiLE (Time Lapse Eeva) Clinical Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

976

Participants

Timeline

Start Date

June 29, 2015

Primary Completion Date

February 9, 2017

Study Completion Date

February 9, 2017

Conditions
Fertility
Interventions
DEVICE

Eeva

Embryos of subjects randomized in this group were assessed using Eeva System and morphological grading to identify optimal embryos for transfer.

Trial Locations (23)

Unknown

Cambrian Wellness Centre, Calgary

One Fertility, Burlington

ISIS Regional Fertility Clinic, Mississauga

Mount Sinai Hospital, Toronto

Rigshospitalet, Copenhagen

CHRU - Hopital Jeanne de Flandres, Lille

Laboratoire Alphabio & Institut de Médecine de la Reproducti, Marseille

Hopital Hotel Dieu, Nantes

Universitatsklinik Schleswig-Holstein, Lübeck

Kinderwunsch Centrum München, Munich

MVZ Kinderwunschzentrum Wiesbaden GmbH, Wiesbaden

Montichiari Università degli studi di Bresca, Montichiari

Istituto Clinico Humanitas, Rozzano

Università degli Studi Torino, Torino

Ospedale Versilia, Viareggio

Telemark hospital Porsgrunn, Skien

Clínica Vistahermosa, Alicante

Clinica Sagrada Familia, Barcelona

Hospital Universitario Virgen de las Nieves, Granada

Fertilitetscentrum Stockholm, Stockholm

Bourn Hall, Cambridge

Birmingham Women's Health Care NHS Trust, Edgbaston

Homerton University Hospital, London

All Listed Sponsors
lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT02417441 - TiLE (Time Lapse Eeva) Clinical Trial | Biotech Hunter | Biotech Hunter